These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 5362859)

  • 1. Persistence of measles antibody in the absence of circulating natural virus five years after immunization of an isolated virgin population with Edmonston B vaccine.
    Brown P; Gajdusek DC; Tsai T
    Am J Epidemiol; 1969 Dec; 90(6):514-8. PubMed ID: 5362859
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on measles in Thailand. IV. Persistence of measles antibody in the absence of natural virus two years after vaccination by the "KL" method.
    Sangkawibha N; Tsuchida P; Bukkavesa S; Ostanonda P; Ueda S
    Biken J; 1971 Jun; 14(2):149-54. PubMed ID: 5122205
    [No Abstract]   [Full Text] [Related]  

  • 3. Measles vaccine reactions in a virgin population.
    Black FL; Woodall JP; Pinheiro FD
    Am J Epidemiol; 1969 Feb; 89(2):168-75. PubMed ID: 5765956
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparison of Edmonston-B and Schwarz measles vaccine in Malian children.
    Jean-Joseph P; Sow S; Casey HL; Imperato PJ; Henderson RH; Noble J
    Lancet; 1969 Mar; 1(7596):665-7. PubMed ID: 4179897
    [No Abstract]   [Full Text] [Related]  

  • 5. Development and evaluation of the Moraten measles virus vaccine.
    Hilleman MR; Buynak EB; Weibel RE; Stokes J; Whitman JE; Leagus MB
    JAMA; 1968 Oct; 206(3):587-90. PubMed ID: 5695578
    [No Abstract]   [Full Text] [Related]  

  • 6. Measles vaccine: immunity, reinfection and revaccination.
    Linnemann CC
    Am J Epidemiol; 1973 Jun; 97(6):365-71. PubMed ID: 4713932
    [No Abstract]   [Full Text] [Related]  

  • 7. Measles in children previously vaccinated against measles.
    Lerman SJ; Gold E
    JAMA; 1971 May; 216(8):1311-4. PubMed ID: 4102807
    [No Abstract]   [Full Text] [Related]  

  • 8. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
    J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Field evaluation of combined more attenuated live measles (Moraten)-smallpox vaccine in Honduras and Costa Rica.
    Villarejos VM; Rodríguez-Aragonés A; Gúnera N; Arguedas JA; Buynak EB; Hilleman MR
    Am J Epidemiol; 1971 May; 93(5):384-91. PubMed ID: 5556398
    [No Abstract]   [Full Text] [Related]  

  • 10. Persistence of immunity following monovalent and combined live measles, mumps, and rubella virus vaccines.
    Weibel RE; Buynak EB; Stokes J; Hilleman MR
    Pediatrics; 1973 Mar; 51(3):467-75. PubMed ID: 4707864
    [No Abstract]   [Full Text] [Related]  

  • 11. One-year follow-up study of measles vaccine antibodies.
    Med J Aust; 1968 Nov; 2(19):831-3. PubMed ID: 5728208
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of the vaccination of a misture of inactivated and live measles vaccines. 1. Clinicoserological observation for a period of 4 years].
    Tanaka H
    Nihon Shonika Gakkai Zasshi; 1972 Mar; 76(3):162-9. PubMed ID: 5065657
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on further attenuated live measles vaccine. IV. Clinical and serological evaluation of a clone of CAM-CEF measles vaccine virus.
    Ueda S; Takahashi M; Kurimura T; Ogino T; Suzuki N
    Biken J; 1970 Sep; 13(3):169-74. PubMed ID: 5530511
    [No Abstract]   [Full Text] [Related]  

  • 14. Measles antibody in previously immunized children. The need for revaccination.
    Linnemann CC; Dine MS; Bloom JE; Schiff GM
    Am J Dis Child; 1972 Jul; 124(1):53-7. PubMed ID: 5033750
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunologic structure of the population characterizing measles susceptibility and its change with massive active immunization].
    Tsipershtein MIa; Shekhter AB
    Zh Mikrobiol Epidemiol Immunobiol; 1972 May; 49(5):39-42. PubMed ID: 5037761
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined live measles, mumps, and rubella virus vaccines.
    Buynak EB; Weibel RE; Whitman JE; Stokes J; Hilleman MR
    JAMA; 1969 Mar; 207(12):2259-62. PubMed ID: 5818433
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on further attenuated live measles vaccine. 3. Selection of less reactive variants of CAM measles vaccine virus.
    Takaku K; Sasada T; Konobe T; Onishi K; Ueda S
    Biken J; 1970 Sep; 13(3):163-8. PubMed ID: 5530510
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on further attenuated live measles vaccine. VIII. Estimated duration of immunity after vaccination without natural infection.
    Ueda S; Okuno Y; Sakamoto Y; Sangkawibha N; Tuchinda P
    Biken J; 1974 Mar; 17(1):11-20. PubMed ID: 4854462
    [No Abstract]   [Full Text] [Related]  

  • 19. A seroepidemiologic study of a measles epidemic in a highly immunized population.
    Linnemann CC; Rotte TC; Schiff GM; Youtsey JL
    Am J Epidemiol; 1972 Mar; 95(3):238-46. PubMed ID: 5010820
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anti-measles vaccination with the Schwarz hyperattenuated live vaccine; post-vaccinal virological study and serological examination for 2 years].
    Boué A; Celers J
    Pathol Biol; 1967 Jan; 15(1):65-70. PubMed ID: 5340408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.